Regulation and Functional Dissection of YAP in Mitosis
Regulation and Functional Dissection of YAP in Mitosis
批准号:
8614249
负责人:
Jixin Dong
金额:
$28.6万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-01-10 至 2018-12-31
关键词:
AneuploidyApoptosisBiologicalCDC2 Protein KinaseCancer EtiologyCell Cycle RegulationCell ProliferationCellsChromosomal InstabilityChromosome SegregationContact InhibitionDefectDissectionDrug TargetingEnsureFutureGenomic InstabilityGoalsHuman CharacteristicsLightLinkMalignant NeoplasmsMediatingMitosisMitoticMitotic Cell CycleMolecularOncogene ProteinsOncogenicOrganOutcomePathway interactionsPhosphorylationPhosphotransferasesPlayPropertyProteinsRegulationRoleSignal PathwaySiteStem cellsTestingTissuesTumor Suppressor ProteinsWorkbasecancer typeinsightmetaplastic cell transformationmutantnew therapeutic targetnoveloverexpressionprotein functionpublic health relevanceself-renewaltherapeutic developmenttherapeutic targettumorigenesis
中文摘要
摘要文本
Hippo通路控制细胞接触抑制、干细胞自我更新和肿瘤发生
通过磷酸化和失活下游癌蛋白,
(雅普)。PI和其他人沿着已经证明雅普通过以下方式促进肿瘤发生:
刺激细胞增殖和抑制凋亡。雅普在细胞中过度表达或过度活化,
多种癌症。目前涉及雅普的研究集中在确定其
在各种器官/组织中的总体致癌作用以及其在与其他组织/组织的相互干扰中的作用
信号通路虽然这些研究提供了重要的洞察致癌特性
然而,雅普的潜在分子机制,通过它雅普发挥其作用,
致癌功能知之甚少。本项目的长期目标是阐明
Hippo-YAP信号通路在有丝分裂细胞周期控制中的调节机制,
致癌转化,从而提供潜在的治疗靶点。
我们的初步研究表明,在有丝分裂过程中,雅普在新的位点被磷酸化
并以CDK 1依赖性方式激活。重要的是,有丝分裂磷酸化是必需的,
YAP驱动的细胞转化。我们已经发现,雅普是激活
纺锤体检查点。此外,雅普的过表达,而非YAP的过表达,
在一些实施方案中,可磷酸化的突变体过度激活纺锤体检查点并导致有丝分裂缺陷。
基于这些初步研究,我们假设CDK 1介导的有丝分裂磷酸化
雅普在调节纺锤体检查点激活方面具有生物学意义,
随后的致癌转化。我们的中心假设将通过
具体目标有以下三个:目标1:明确雅普的分子机制
目的2:确定雅普及其磷酸化在有丝分裂中的作用,
有丝分裂进程、纺锤体检查点和非整倍体;目的3:确定功能性
雅普磷酸化对其靶点的重要性。成功完成这些研究将
不仅揭示了雅普在有丝分裂和基因组不稳定性中的新作用,
参与YAP驱动的肿瘤发生的机制。
英文摘要
Abstract Text
The Hippo pathway controls cell contact inhibition, stem cell self -renewal, and tumorigenesis
through phosphorylating and inactivating the downstream oncoprotein, yes-associated protein
(YAP). The PI, along with others, has demonstrated that YAP promotes oncogenesis by
stimulating cell proliferation and inhibiting apoptosis. YAP is overexpressed or hyperactivated in
many types of cancers. Current studies involving YAP focus on determining its
overall oncogenic role in various organs/tissues as well as its role in crosstalk with other
signaling pathways. While these studies provide important insight into the oncogenic properties
of YAP, however, the underlying molecular mechanisms through which YAP exerts its
oncogenic function are poorly understood. The long-term goal of this project is to elucidate the
regulatory mechanisms of the Hippo-YAP signaling pathway in mitotic cell-cycle control and
oncogenic transformation, thus providing potential therapeutic targets.
Our preliminary studies demonstrate that during mitosis YAP is phosphorylated on novel sites
and activated in a CDK1-dependent manner. Importantly, mitotic phosphorylation is required for
YAP-driven cellular transformation. We have found that YAP is required for the activation of the
spindle checkpoint during mitosis. Furthermore, overexpression of YAP, but not of the non -
phosphorylatable mutant, hyper-activates the spindle checkpoint and causes mitotic defects.
Based on these preliminary studies, we hypothesize that CDK1-mediatd mitotic phosphorylation
of YAP is biologically significant in the regulation of the spindle checkpoint activation and
subsequent oncogenic transformation. Our central hypothesis will be tested through the
following three specific aims: Aim 1: Determine the molecular mechanism of YAP
regulation/activation during mitosis; Aim 2: Determine the role of YAP and its phosphorylation in
mitotic progression, the spindle checkpoint, and aneuploidy; Aim 3: Determine the functional
significance of YAP phosphorylation on its targets. Successful completion of these studies will
not only reveal novel roles of YAP in mitosis and genome instability, but will also shed light on
the mechanisms involved in YAP-driven oncogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting MARK2-HDAC signaling to overcome paclitaxel resistance in pancreatic cancer
-
批准号:10518249
-
项目类别:
-
资助金额:$33.23万
-
财政年份:2022
-
负责人:Jixin Dong
-
依托单位:
Targeting MARK2-HDAC signaling to overcome paclitaxel resistance in pancreatic cancer
-
批准号:10707545
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2022
-
负责人:Jixin Dong
-
依托单位:
Targeting PKR-Bcl2 Signaling to Overcome Paclitaxel Resistance in Ovarian Cancer
-
批准号:10502982
-
项目类别:
-
资助金额:$41.34万
-
财政年份:2022
-
负责人:Jixin Dong
-
依托单位:
Targeting PKR-Bcl2 Signaling to Overcome Paclitaxel Resistance in Ovarian Cancer
-
批准号:10672464
-
项目类别:
-
资助金额:$40.52万
-
财政年份:2022
-
负责人:Jixin Dong
-
依托单位:
Regulation and Functional Dissection of YAP in Mitosis
-
批准号:8790759
-
项目类别:
-
资助金额:$28.6万
-
财政年份:2014
-
负责人:Jixin Dong
-
依托单位:
REGULATION AND FUNCTION OF KIBRA IN THE HIPPO SIGNALING PATHWAY
-
批准号:8360441
-
项目类别:
-
资助金额:$27.19万
-
财政年份:2011
-
负责人:Jixin Dong
-
依托单位:
REGULATION AND FUNCTION OF KIBRA IN THE HIPPO SIGNALING PATHWAY
-
批准号:8168390
-
项目类别:
-
资助金额:$27.39万
-
财政年份:2010
-
负责人:Jixin Dong
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: